India 2006g.

Methods	Randomised controlled trial.
Participants	200 women with singleton pregnancy, spontaneous onset of labour at term and vertex presentation admitted in active phase of labour were included. Women with hypertension, cardiac disease, renal disease, gastrointestinal disorders, respiratory disease, endocrinal problems, coagulation disorder, and sensitivity to prostaglandin or methergin were excluded.
Interventions	125 mcg IM PGF2 versus 0.2 mg methergin IV at the time of the anterior shoulder delivery.
Outcomes	Duration of third stage, blood loss, need for additional drugs, retained placenta and side‐effects (nausea and vomiting).
Notes	Active management of third stage of labour. Blood loss was estimated by blood and blood clots collected in the kidney tray.
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Low risk	"random number tables."
Allocation concealment (selection bias)	Unclear risk	Unclear on how the allocation concealment was done.
Blinding (performance bias and detection bias) All outcomes	Unclear risk	Not clear on if the blinding occurred.
Incomplete outcome data (attrition bias) All outcomes	Low risk	No loss to follow‐up and exclusions after randomisation were reported.
Selective reporting (reporting bias)	Unclear risk	Not all of the primary outcomes of the review were reported.
Other bias	Low risk	The 2 groups were well matched in the baseline.